Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 182 clinical trials
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

stabilize or improve kidney function and compare it to the currently used treatment with the angiotensin converting enzyme inhibitor, enalapril, in patients with the complement-mediated renal disease C3

mammogram
kidney biopsy
enzyme inhibitor
  • 17 views
  • 22 Mar, 2022
  • 1 location
Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Long-Term Outcomes

professional society guidelines. GDMT refers to initial medical therapy with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin-receptor blockers (ARB), beta-blockers (BB), and mineralocorticoid

implantable cardioverter-defibrillators
heart failure
cardiac resynchronization therapy
beta blockers
ejection fraction
  • 0 views
  • 04 Oct, 2022
  • 1 location
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE) (INFUSE)

terlipressin, particularly in the splanchnic area, increases effective intravascular volume and mean arterial pressure (MAP), ameliorates renin-angiotensin-aldosterone system and sympathetic nervous system

ascites
aldosterone
renal failure
angiotensin
  • 0 views
  • 23 Apr, 2022
  • 7 locations
Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

/hydrochlorothiazide 25 mg single-pill fixed combination; amlodipine besylate tablet (5 mg/tablet); hydrochlorothiazide tablets (25 mg/tablet) Rationale: Angiotensin-converting enzyme inhibitor (ACEI) or

losartan
ace inhibitor
angiotensin converting enzyme
hydrochlorothiazide
antihypertensive drugs
  • 0 views
  • 06 Feb, 2022
  • 1 location
Transcutaneous Stimulation in Spinal Cord Injury (SCI)

Cardiovascular disease has become the leading cause of death in the spinal cord injury population. Increased reliance on the renin-angiotensin-aldosterone system (RAAS) is believed to decrease

systolic blood pressure
spinal cord disorder
spinal cord
spinal injury
injuries
  • 0 views
  • 13 May, 2022
  • 1 location
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

LCZ696, a molecular complex of the angiotensin receptor blocker (ARB) valsartan with an inhibitor of neprilysin (NEP, neutral endopeptidase-24.11) sacubitril improved mortality compared to

beta-adrenergic blocking agents
enalapril
potassium
heart failure
beta blockers
  • 2 views
  • 14 Jun, 2022
  • 1 location
MR Antagonist and STRIATIN

, hypertension and salt sensitive blood pressure. Key homeostatic mechanisms that regulate renal sodium reabsorption are: first, hormonal, e.g., renin-angiotensin-aldosterone system and second, vascular, e.g

Accepts healthy volunteers
ace inhibitor
angiotensin converting enzyme
antihypertensive drugs
angiotensin
  • 4 views
  • 24 Feb, 2022
  • 1 location
The Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart Failure

Heart failure (HF) is a complex syndrome with increasing incidence and high rates of mortality and hospitalization. Although inhibitors of angiotensin converting enzyme (ACE), -blockers and

aldosterone
heart failure
nt-probnp
angiotensin converting enzyme
chronic heart failure
  • 0 views
  • 22 Aug, 2021
  • 1 location
Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

sympathetic nervous system stimulating reabsorption of sodium in proximal,distal tubules, loop of Henle and collecting duct as well as the renin-angiotensin-aldosterone system, leading to sodium absorption

ascites
paracentesis
cytokines
carvedilol
spontaneous bacterial peritonitis
  • 0 views
  • 06 Nov, 2021
  • 1 location
Cohort of Heart Failure Patients (LOOP-HF)

is based on precise international recommendations. The association of Beta-Blockers, renin-angiotensin system blockers, mineralocorticoid receptor antagonists, represent the basis of the

beta-adrenergic blocking agents
heart failure
cardiac resynchronization therapy
beta blockers
angiotensin
  • 22 views
  • 26 Feb, 2022